UK markets open in 6 hours 20 minutes

Immunocore Holdings plc (IMCR)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
59.46+0.41 (+0.69%)
At close: 04:00PM EDT
59.45 -0.01 (-0.02%)
After hours: 05:51PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 2.95B
Enterprise value 2.51B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)9.22
Price/book (mrq)6.37
Enterprise value/revenue 10.04
Enterprise value/EBITDA -48.50

Trading information

Stock price history

Beta (5Y monthly) 0.89
52-week change 30.75%
S&P500 52-week change 323.57%
52-week high 376.98
52-week low 342.21
50-day moving average 361.78
200-day moving average 359.54

Share statistics

Avg vol (3-month) 3408.83k
Avg vol (10-day) 3415.94k
Shares outstanding 550.01M
Implied shares outstanding 650.8M
Float 832.44M
% held by insiders 19.62%
% held by institutions 181.56%
Shares short (15 Apr 2024) 44.09M
Short ratio (15 Apr 2024) 410.64
Short % of float (15 Apr 2024) 49.32%
Short % of shares outstanding (15 Apr 2024) 48.18%
Shares short (prior month 15 Mar 2024) 44.29M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -22.17%
Operating margin (ttm)-26.28%

Management effectiveness

Return on assets (ttm)-6.74%
Return on equity (ttm)-15.62%

Income statement

Revenue (ttm)249.43M
Revenue per share (ttm)5.10
Quarterly revenue growth (yoy)12.20%
Gross profit (ttm)N/A
EBITDA -56.46M
Net income avi to common (ttm)-55.29M
Diluted EPS (ttm)-1.42
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)442.63M
Total cash per share (mrq)8.88
Total debt (mrq)84.03M
Total debt/equity (mrq)22.78%
Current ratio (mrq)3.80
Book value per share (mrq)7.42

Cash flow statement

Operating cash flow (ttm)2.94M
Levered free cash flow (ttm)14.06M